Home » BGI, Merck Agree to Explore Areas of Interest in Next-gen Sequencing

BGI, Merck Agree to Explore Areas of Interest in Next-gen Sequencing

Sep 15, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BGI today announced that it has signed a statement of intent with drug giant Merck to explore areas of mutual interest with the goal of "creating value" from the high volume of information resulting from next-generation sequencing technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

More to Do

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

To Control the Spread

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

This Week in PLOS

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

'Follow Me to Maryland'

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

What's Popular?

In Clinical Sequencing

  1. Nanopore Sequencing Becomes More Portable to Enable Outbreak Surveillance in Field

    Premium

  2. Geisinger Exome Study IDs Breast Cancer Risk Variants That May Not Have Been Detected in Routine Care

  3. GeneCentric Licenses UNC Pancreatic Cancer Subtyping Tech

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.